Immunovant, Inc.
IMVT- 交易所
- Nasdaq
- 產業
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001764013
近 90 天，Immunovant, Inc. 內部人申報 0 筆公開市場買進、10 筆賣出；2026 年第 2 季末有 226 家機構在 13F 申報持有，市值合計 $42.5 億；大師中只有綠光資本持有。
持有 IMVT 5% 以上的大股東
最新一份 Schedule 13D 或 13G 申報持有 Immunovant, Inc. 5% 以上的持有人，依持股比例由大到小；變化是跟這位持有人的上一份申報比。
| 持有人 | 最新表單 | 持股 | 變化 | 首次申報 | 最新申報 | 原文 |
|---|---|---|---|---|---|---|
| Roivant Sciences Ltd. | 13D/A | 55.90%股數 1.13 億 | −1.00 個百分點原本 56.90% | 2021/3/86 份 | 2025/12/12 | SEC |
| FMR LLC | 13G/A | 8.40%股數 1,473 萬 | −1.70 個百分點原本 10.10% | 2024/2/94 份 | 2025/11/5 | SEC |
持股是每位持有人最新一份申報的數字。最後一份是舊格式（2024 年 12 月 18 日以前）的持有人沒有持股比例紀錄，不列在這裡；公司被收購或下市之後，持有人通常就不再申報。
13D 與 13G 申報
Immunovant, Inc. 的 18 份 Schedule 13D、13G 申報，由新到舊，包括沒有持股比例的舊格式申報。
| 申報時間（美東） | 申報人 | 表單 | 持股 | 變化 | 事件日 | 原文 |
|---|---|---|---|---|---|---|
| 2026/8/1408:27 ET | Deep Track Capital, LP等 3 位 | 13G/A | 4.55%股數 934.1 萬 | −1.04 個百分點原本 5.59%低於 5% | 2026/6/30 | SEC |
| 2025/12/1217:20 ET | Roivant Sciences Ltd. | 13D/A | 55.90%股數 1.13 億 | −1.00 個百分點原本 56.90% | 2025/12/12 | SEC |
| 2025/11/511:35 ET | FMR LLC等 2 位 | 13G/A | 8.40%股數 1,473 萬 | −1.70 個百分點原本 10.10% | 2025/9/30 | SEC |
| 2025/4/2107:54 ET | Roivant Sciences Ltd. | 13D/A | 56.90%股數 9,666 萬 | 0.00 個百分點原本 56.90% | 2025/4/21 | SEC |
| 2025/3/2616:09 ET | Deep Track Capital, LP等 3 位 | 13G | 5.59%股數 950.0 萬 | – | 2025/3/19 | SEC |
| 2025/3/710:01 ET | FMR LLC等 2 位 | 13G/A | 10.10%股數 1,708 萬 | – | 2025/2/28 | SEC |
| 2025/1/1516:30 ET | Roivant Sciences Ltd. | 13D/A | 56.90%股數 9,666 萬 | – | 2025/1/13 | SEC |
| 2024/11/12 | FMR LLC | 13G/A舊制 | – | – | – | SEC |
| 2024/2/14 | Deep Track Capital, LP | 13G/A舊制 | – | – | – | SEC |
| 2024/2/9 | FMR LLC | 13G舊制 | – | 新申報 | – | SEC |
| 2023/10/4 | Roivant Sciences Ltd. | 13D/A舊制 | – | – | – | SEC |
| 2023/2/14 | Deep Track Capital, LP | 13G/A舊制 | – | – | – | SEC |
| 2022/12/5 | RTW Investments, LP | 13G/A舊制 | – | – | – | SEC |
| 2022/12/2 | RTW Investments, LP | 13G/A舊制 | – | – | – | SEC |
| 2022/2/11 | Deep Track Capital, LP | 13G舊制 | – | 新申報 | – | SEC |
| 2021/8/2 | Roivant Sciences Ltd. | 13D/A舊制 | – | – | – | SEC |
| 2021/3/8 | Roivant Sciences Ltd. | 13D/A舊制 | – | – | – | SEC |
| 2021/2/16 | RTW Investments, LP | 13G/A舊制 | – | – | – | SEC |
Form 144：內部人預計賣出
高階主管、董事與其他關係人預計賣出 Immunovant, Inc. 股票的 27 份通知，由新到舊。
| 申報時間（美東） | 賣方 | 預計賣出股數 | 市值 | 預計賣出日 | 券商 | 原文 |
|---|---|---|---|---|---|---|
| 2026/11/1207:58 ET | Atul Pande董事 | 6,000 | $21.4 萬 | 2026/11/1110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/2616:25 ET | Jay S Stout高階主管 | 4.00 萬 | $153.2 萬 | 2026/6/26 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/2616:22 ET | Chris Adair Van Tuyl高階主管 · 董事 | 1.78 萬 | $68.3 萬 | 2026/6/26 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/2616:20 ET | Melanie Gloria高階主管 | 1.77 萬 | $67.9 萬 | 2026/6/26 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/2616:18 ET | Tiago Girao高階主管 | 1.00 萬 | $38.5 萬 | 2026/6/26 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/6/1516:35 ET | Atul Pande董事 | 6,000 | $20.2 萬 | 2026/6/1510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/5/2816:12 ET | Andrew J Fromkin董事 | 22.2 萬 | $743.9 萬 | 2026/5/28 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/5/2016:37 ET | Atul Pande董事 | 6,000 | $15.8 萬 | 2026/5/2010b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/5/116:46 ET | Robert G Susman董事 | 2,502 | $6.79 萬 | 2026/5/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2026/2/1017:16 ET | Michael Geffner高階主管 | 5,800 | $15.5 萬 | 2026/2/10 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/12/116:35 ET | Andrew J Fromkin董事 | 2.22 萬 | $53.7 萬 | 2025/12/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/12/116:34 ET | Douglas Hughes董事 | 1.50 萬 | $36.2 萬 | 2025/12/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/11/2617:07 ET | Michael Geffner高階主管 | 5.00 萬 | $118.5 萬 | 2025/11/26 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/11/2519:16 ET | Michael Geffner高階主管 | 10.4 萬 | $242.9 萬 | 2025/11/25 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/6/2516:02 ET | William Macias高階主管 | 3.00 萬 | $47.5 萬 | 2025/6/25 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/6/1317:34 ET | William Macias高階主管 | 5.00 萬 | $77.8 萬 | 2025/6/13 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/6/317:42 ET | William Macias高階主管 | 8.00 萬 | $124.9 萬 | 2025/6/3 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/2116:24 ET | George V Migausky前董事 | 2.18 萬 | $31.8 萬 | 2025/5/21 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/5/1916:40 ET | George V Migausky前董事 | 2.82 萬 | $41.1 萬 | 2025/5/19 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/3/716:17 ET | Andrew J Fromkin董事 | 8,000 | $15.6 萬 | 2025/3/710b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/2/1416:11 ET | Mark S Levine前關係人 | 6.98 萬 | $140.7 萬 | 2025/2/14 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2025/2/1116:11 ET | Mark S Levine前關係人 | 2.92 萬 | $57.0 萬 | 2025/2/11 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/12/216:33 ET | Douglas J. Hughes高階主管 | 5,425 | $15.3 萬 | 2024/12/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2024/12/216:33 ET | Atul Chandra Pande董事 | 7,750 | $21.9 萬 | 2024/12/210b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| 2023/12/116:20 ET | Atul Chandra Pande董事 | 1.24 萬 | $48.3 萬 | 2023/12/110b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
只列最新的 25 份。看 IMVT 近 12 個月的全部通知